Abstract The European Cooperation in Science and Technology (COST) provides an ideal
framework to establish multi-disciplinary research networks. COST Action BM1203 (EU …

Peripheral arterial disease (PAD) is caused by occlusive atherosclerosis in a vascular bed
other than the heart. The lower extremity is the most-common location for PAD. Critical limb …

There is a clinical need for new, more effective treatments for chronic wounds in diabetic
patients. Lack of epithelial cell migration is a hallmark of nonhealing wounds, and diabetes …

Introduction‐Angiogenesis in physiology and pathology‐Angiogenesis in current medicine‐
VEGF ligand and receptor system: where does sVEGFR1 fit?‐Ligands: the human VEGF …

Objective—In response to tissue injury, the appropriate progression of events in
angiogenesis is controlled by a careful balance between pro and antiangiogenic factors. We …

Peripheral arterial disease (PAD) is a common vascular disease that reduces blood flow
capacity to the legs of patients. PAD leads to exercise intolerance that can progress in …

Impaired angiogenesis in diabetes is a key process contributing to ischemic diseases such
as peripheral arterial disease. Epigenetic mechanisms, including those mediated by long …

Several cytokine families have roles in the development, maintenance, and remodeling of
the microcirculation. Of these, the vascular endothelial growth factor (VEGF) family is one of …

Endothelial dysfunction is a central hallmark of diabetes. The transcriptional coactivator PGC-
1α is a powerful regulator of metabolism, but its role in endothelial cells remains poorly …

In patients with diabetes mellitus, the ability of ischemic tissue to synchronize the molecular
and cellular events leading to restoration of tissue perfusion in response to the …